Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06712654
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of AP306 At Fixed Doses in Patients with Hyperphosphatemia

Who this might be right for
HyperphosphatemiaChronic Kidney Disease Requiring Hemodialysis
Alebund Pharmaceuticals 144
Not applicableStudy completedNCT01901107
What this trial is testing

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Who this might be right for
Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis
Astellas Pharma Inc 1,078
Testing effectiveness (Phase 2)Study completedNCT05764590
What this trial is testing

Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients

Who this might be right for
Chronic Kidney DiseasesHyperphosphatemia
Alebund Pharmaceuticals 55
Testing effectiveness (Phase 2)Study completedNCT04551300
What this trial is testing

Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients

Who this might be right for
Hyperphosphatemia
Shanghai Alebund Pharmaceuticals Limited 158

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation